Fatigue in Lupus Intervention Programmes (FLIP)
Launched by UNIVERSITY OF EDINBURGH · Mar 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Fatigue in Lupus Intervention Programmes (FLIP) trial is studying ways to help people with Systemic Lupus Erythematosus (SLE) manage their fatigue, which can greatly affect their daily lives. The trial will compare two approaches: one group will receive a virtual Fatigue Management Programme along with a helpful booklet, while another group will only receive the booklet. The goal is to see if the virtual program is more effective in reducing fatigue. The study also looks at whether a shorter 4-week program can be just as helpful as the standard 7-week program, making it easier for people to participate.
To be eligible for this trial, participants need to be over 18 years old, have a confirmed diagnosis of SLE, and have been experiencing significant fatigue recently. They should also be comfortable using a computer or smartphone for online sessions and be able to read and speak English. If you choose to join, you'll complete some questionnaires and may be randomly assigned to one of the two groups. The study is taking place in Edinburgh, and the researchers aim to find a cost-effective solution to help patients deal with fatigue more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Have a confirmed SLE Diagnosis
- • 2. Be over 18 at time of consent
- • 3. Report fatigue to be a chronic problem in the last 4 weeks with a VAS fatigue impact ≥ 6, based on a scale of 1 ( no fatigue impact on quality of life ) to 10 (severe impact of fatigue on quality of life).\[20\]
- • 4. Agree to online consent, complete questionnaires and be randomised to standard care or group intervention programme via secure server (REDCap).
- • 5. Not have taken part in a group fatigue or pain management programme in the past 5 years.
- • 6. Have the ability to read and converse in English competently
- • 7. Have access to a computer/Smartphone/Tablet for internet and audio/video access.
- • 8. Be able to or willing to learn to use an NHS approved platform.
- • 9. Be willing to provide a telephone, postal address and email address for communication related to the FLIP trial.
- Exclusion Criteria:
- • 1. They are unable to understand English sufficiently to attend a live online group programme. Facilitators and other group members will most likely only speak English.
- • 2. They are unable to provide confirmation of eligibility, complete online informed consent or questionnaires
- • 3. They are currently participating in an interventional trial
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, , United Kingdom
Patients applied
Trial Officials
Helen Harris, BA MB BCh BAO
Principal Investigator
University of Edinburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported